Access brought to you by: LOCKSS

Cardiology Clinical Trials

First-in-Man Results Show That a Leadless Catheter Pacemaker is Feasible, Safe, and Effective
Reablation Superior to Antiarrhythmic Drug Therapy after a Failed Ablation Procedure
Improving Clinician Adherence to Evidence-Based Recommendations Reduces Unnecessary ICD Shocks
Driver Mapping and Driver-Guided Ablation Reduces Need for Antiarrhythmic Medication
Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina
Digoxin Reduces 30-Day Hospital Admission in Older Ambulatory Patients with Heart Failure
Early Fibrinolysis as Effective as Primary PCI When Reperfusion Delay is Long
New SAPIEN XT System is Noninferior to and Safer Than Old SAPIEN System
MASS COM Trial: Nonemergency PCI Safe without on-Site Surgery Capability
ASTRONAUT Study: Aliskiren Does Not Improve Postdischarge Outcomes in Patients Hospitalized for Chronic Heart Failure

Pages